Lipocine Correlations
LPCN Stock | USD 4.47 0.05 1.11% |
The current 90-days correlation between Lipocine and Unicycive Therapeutics is -0.16 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipocine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipocine moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Lipocine Correlation With Market
Good diversification
The correlation between Lipocine and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and DJI in the same portfolio, assuming nothing else is changed.
Lipocine |
Moving together with Lipocine Stock
0.81 | INZY | Inozyme Pharma | PairCorr |
0.65 | LPTX | Leap Therapeutics | PairCorr |
0.79 | MREO | Mereo BioPharma Group | PairCorr |
0.66 | NKTX | Nkarta Inc | PairCorr |
0.76 | PDSB | PDS Biotechnology Corp | PairCorr |
0.62 | PLRX | Pliant Therapeutics | PairCorr |
0.65 | ABBV | AbbVie Inc Earnings Call Tomorrow | PairCorr |
0.72 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.65 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.65 | AMGN | Amgen Inc Earnings Call This Week | PairCorr |
0.67 | APTO | Aptose Biosciences | PairCorr |
0.7 | TERN | Terns Pharmaceuticals Buyout Trend | PairCorr |
0.72 | ACET | Adicet Bio | PairCorr |
Moving against Lipocine Stock
0.58 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
0.4 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
0.33 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
0.49 | CDXS | Codexis | PairCorr |
0.48 | BPMC | Blueprint Medicines Corp Sell-off Trend | PairCorr |
0.36 | PTCT | PTC Therapeutics | PairCorr |
0.55 | MNPR | Monopar Therapeutics | PairCorr |
0.51 | DNOW | Now Inc | PairCorr |
0.37 | DNA | Ginkgo Bioworks Holdings Upward Rally | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lipocine Stock performing well and Lipocine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lipocine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SGTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RVPH | 7.08 | 1.49 | 0.15 | 1.19 | 8.25 | 18.87 | 71.13 | |||
ZVSA | 5.85 | (0.35) | 0.00 | (0.03) | 0.00 | 13.76 | 78.93 | |||
KRBP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
UNCY | 4.35 | 0.20 | 0.04 | 0.24 | 4.85 | 9.59 | 28.72 | |||
CKPT | 3.92 | (0.21) | 0.00 | 0.60 | 0.00 | 8.15 | 18.94 | |||
MBIO | 5.20 | (1.10) | 0.00 | 0.44 | 0.00 | 15.38 | 53.88 | |||
FBIOP | 2.82 | 0.36 | 0.06 | (0.39) | 3.01 | 7.44 | 21.73 | |||
KOD | 5.27 | 1.11 | 0.18 | 0.80 | 5.68 | 11.39 | 45.02 | |||
ARDX | 3.69 | (0.11) | 0.00 | (0.19) | 0.00 | 8.32 | 33.99 |
Lipocine Corporate Management
CPA CPA | Co Sec | Profile | |
Logan Morse | Marketing Sales | Profile | |
Nachiappan Chidambaram | Senior Development | Profile | |
M MD | Chief Director | Profile | |
Krista Fogarty | Principal Controller | Profile |